GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Tariff Resilience Score

Novartis AG (MEX:NVS N) Tariff Resilience Score : 8/10 (As of Jul. 07, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Tariff Resilience Score?

Novartis AG has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Novartis AG has Novartis, a global pharmaceutical giant, has a robust supply chain and significant pricing power. Its essential healthcare products often receive tariff exemptions, making it highly resilient to trade policy changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Novartis AG might have Highly Resilient.

Competitive Comparison of Novartis AG's Tariff Resilience Score

For the Drug Manufacturers - General subindustry, Novartis AG's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG's Tariff Resilience Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Novartis AG's Tariff Resilience Score falls into.


;
;

Novartis AG  (MEX:NVS N) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Novartis AG Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Novartis AG's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Tariff Resilience Score
Comparable Companies
XSWX:ROG XSWX:COPN LLY JNJ ABBV OCSE:NOVO B LSE:AZN MRK AMGN GILD PFE XPAR:SAN BMY TSE:4519 LSE:GSK SHSE:600276 TSE:4568 XTER:BAYN TSE:4578 BIIB
Traded in Other Exchanges
NVSEF:USA NVS:USA NOVN:Mexico 1NOVN:Italy NOVNz:UK 0K9E:UK 0QLR:UK NOT0:Germany NOTA:Germany NOT:Germany NOT:Germany NOTA:Germany NOT:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines